AVEO – Smarter Investing

My philosophy is simple: buy low and sell high.

Strategies

On being a Volvo investor in a Maserati market

By any number of measures this market is getting pricey.

Strategies

The FDA’s rejection of Aveo's Tivozanib is a stunner.

Strategies

The FDA has let down renal cancer patients with its Tivozanib decision.

Strategies

Aveo's Tivozanib kidney cancer drug will get the nod from regulators.

Strategies

After taking a beating, Bank of America's stock has staged an impressive comeback.

Strategies

Bank of American could be a break-out financial play next year.

Strategies

Danger always lies where there is a crowd. Today the crowd thinks safety is safe.

Strategies

Across the board the relative safety profile of Tivo stands out.

Strategies

A Q&A with Chris Rees of Ten Stocks about his strategy going into 2012.

The runway for a successful HTCH recovery is now significantly shorter due to the Thai flood disaster.

Strategies